Radiofrequency ablation (RFA), is a medical procedure in which part of the
electrical conduction system of the heart, tumor or other dysfunctional tissue is
ablated using the heat generated from alternating current.
Two important advantages of radio frequency current are that it does not di-
rectly stimulate nerves or heart muscle and therefore can often be used with-
out the need for general anesthesia, and that it is very specific for treating the
desired tissue without significant collateral damage; due to this, it is gaining in
popularity as an alternative for eligible patients who do not want to undergo
surgery
A biopsy is a procedure to remove a piece of tissue or a sample of cells from your body so that it can be tested in a laboratory. You may undergo a biopsy if you're experiencing certain signs and symptoms or if your health care provider has identified an area of concern. A biopsy can determine whether you have cancer or another condition.
Imaging tests, such as CT scans or MRIs, are helpful in detecting masses or irregular tissue, but they alone can't tell the difference between cancerous cells and cells that aren't cancerous.
Microwave ablation uses electromagnetic waves in the microwave energy spectrum to produce tissue-heating effects. The oscillation of polar molecules produces frictional heating, ultimately generating tissue necrosis within solid tumors.
Thrombosis aspiration system is designed to remove thrombus from vasculature using continuous aspiration. A catheter is introduced into the vasculature and then the site of occlusion, used together with the aspiration pump, to aspirate thrombosis from the occluded vessel. The separator may be used to help clean the thrombosis
We’ve compiled some information on the various conditions that our products are designed to treat: what they are, what causes them, how to prevent them, and what therapeutic options are available for them (including ours, of course). We hope the explanations help you navigate your own healthcare journey
Minimax Medical Group is a pioneering MedTech enterprise strategically located in China & Europe, and strongly committed to research, manufacture and sales of minimally invasive devices and surgical robot.
Our self-owned minimally invasive products have established strong supply and market presence in key global marketplaces, ranging from oncology, phle- bology, proctology and aesthetic dermatology. Particularly in China, we have achieved sales of our self-owned brands and devices under distribution in hun- dreds of 3A-graded Chinese hospitals, and we are proactively capturing oppor- tunities in 2A-grades across the country. We are now vigorously expanding our international brand identity.
17th China Southern Endovascular Conference (SEC Annual Meeting 2024) took place on 18-21 July in Guangzhou, China. Numerous experts and scholars from home and abroad participated in the congress, and conducted extensive and in-depth discussions on current global vascular disease hot topics. The scope covered clinical diagnosis and treatment, evidence-based medicine, hot spot focus areas, medical innovation and transformation, application of new theories and technologies, complications preventio
2024/9/10
Life Through Technology Symposium was held by Angiodynamics in Monte Carlo from 24th November to 26th November. The event highlighted the creative energy to be found between clinical and industrial players in the fields of surgery, oncology, urolo...
2024/9/11
